Infectious risk and retroviral restriction factors in xenotransplantation |
| |
Authors: | E. Dörrschuck C. Münk R. R. Tönjes |
| |
Affiliation: | 1. Universit?tsklinikum des Saarlandes, Clinic for Pediatric Cardiology, Homburg/Saar, Germany;2. Heinrich‐Heine‐Universit?t, Clinic for Gastroenterology, Hepatology and Infectiology, Düsseldorf, Germany;3. Paul‐Ehrlich‐Institute, Division of Medical Biotechnology, Langen, Germany |
| |
Abstract: | The clinical application of xenotransplantation evokes immunological and microbiological as well as virological challenges. Porcine pathogens that do not show any symptoms in their natural host could exhibit a risk of fatal infections to humans. The presence of pig infectious agents including zoonotic and dissimilar agents should be reduced by specific pathogen free (spf) breeding of donor animals. However, the genetic information of porcine endogenous retroviruses (PERV) is integrated in the pig genome and can not be eradicated by spf breeding. The concerns about PERV for human xenograft recipients are based on data of in vitro replication of PERV in some human cell lines. So far, viral replication of PERV has been difficult to demonstrate in non‐human primate cell lines and in preclinical studies of non‐human primates receiving porcine xenografts, respectively. In this regard, natural and effective mechanisms of human and porcine cells counteracting productive infections caused by PERV are important to investigate. Intracellular proteins and components of the innate immune system including endogenous “antiretroviral restriction factors” act at various steps in retroviral replication. The cellular front is composed by several constitutively expressed genes which prevent or suppress retroviral infections. Some of these factors such as members of the tripartite motif (TRIM) and the apolipoprotein B mRNA‐editing polypeptide (APOBEC) families as well as tetherin and zinc‐finger antiviral protein (ZAP) could be useful in the management of PERV in xenotransplantation. The risks of infection and the potential role of antiretroviral restriction factors in xenotransplantation are presented in detail. |
| |
Keywords: | |
|
|